Bill Text: VA SB187 | 2010 | Regular Session | Prefiled
Bill Title: Anti-epileptic drug; prohibits pharmacist from dispensing without prior notification from physician.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2010-01-28 - Senate: Stricken at request of patron in Education and Health (13-Y 0-N) [SB187 Detail]
Download: Virginia-2010-SB187-Prefiled.html
10103514D Be it enacted by the General Assembly of Virginia: 1. That §54.1-3408.03 of the Code of Virginia is amended and reenacted and that the Code of Virginia is amended by adding a section numbered 54.1-3408.04 as follows: §54.1-3408.03. Dispensing of therapeutically equivalent drug product permitted. A. A pharmacist may dispense a therapeutically equivalent drug
product for a prescription that is written for a brand-name drug product unless
(i) the prescriber indicates such substitution is not authorized by specifying
on the prescription, "brand medically necessary,"
In the case of an oral prescription, the prescriber's oral dispensing instructions regarding substitution shall be followed. B.
§54.1-3408.04. Dispensing of therapeutically equivalent anti-epileptic drug product prohibited. A. A pharmacist may not interchange any anti-epileptic drug without prior notification of, and the signed informed consent for, such interchange from the prescribing physician and the patient or his legal guardian or representative. B. For the purposes of this section: "Anti-epileptic drug" means (i) any drug prescribed for the treatment of epilepsy or (ii) any drug used to treat or prevent seizures. "Epilepsy" means a neurological condition characterized by recurrent seizures. "Interchange" means the substitution of one version of the same anti-epileptic drug product, including a generic version for the prescribed brand, a brand version for the prescribed generic version, or a generic version by one manufacturer for a generic version by a different manufacturer for the anti-epileptic drug product originally dispensed. "Seizure" means an acute clinical change secondary to a brief disturbance in the electrical activity of the brain. |